APA (7th ed.) Citation

Cummings, J., Aisen, P., Lemere, C., Atri, A., Sabbagh, M., & Salloway, S. (2021). Aducanumab produced a clinically meaningful benefit in association with amyloid lowering. Alzheimer's research & therapy, 13(1), 98-3. https://doi.org/10.1186/s13195-021-00838-z

Chicago Style (17th ed.) Citation

Cummings, Jeffrey, Paul Aisen, Cynthia Lemere, Alireza Atri, Marwan Sabbagh, and Stephen Salloway. "Aducanumab Produced a Clinically Meaningful Benefit in Association with Amyloid Lowering." Alzheimer's Research & Therapy 13, no. 1 (2021): 98-3. https://doi.org/10.1186/s13195-021-00838-z.

MLA (9th ed.) Citation

Cummings, Jeffrey, et al. "Aducanumab Produced a Clinically Meaningful Benefit in Association with Amyloid Lowering." Alzheimer's Research & Therapy, vol. 13, no. 1, 2021, pp. 98-3, https://doi.org/10.1186/s13195-021-00838-z.